86:@0.092505:0.957873:0.109687:0.957873:0.109687:0.938882:0.092505:0.938882:0.008591:0.008591
3:@0.038824:0.310836:0.060302:0.310836:0.060302:0.263358:0.038824:0.263358:0.021478
CHAPTER 3:@0.117647:0.067219:0.190423:0.067219:0.190423:0.047140:0.117647:0.047140:0.009172:0.009650:0.008799:0.008861:0.007388:0.007906:0.009359:0.003320:0.008321
Acknowledgements:@0.117647:0.126494:0.323305:0.126494:0.323305:0.098384:0.117647:0.098384:0.012144:0.012841:0.012492:0.013626:0.012957:0.018652:0.010285:0.011069:0.013103:0.013074:0.011069:0.017286:0.011069:0.013626:0.010223:0.012144
We thank members of the Kloosterman and Cuppen laboratories for helpful discus-:@0.117647:0.168344:0.852941:0.168344:0.852941:0.147971:0.117647:0.147971:0.018649:0.009039:0.007053:0.006620:0.011391:0.009085:0.011870:0.010523:0.007053:0.017485:0.009039:0.017394:0.011254:0.009039:0.007624:0.007670:0.007053:0.010843:0.006209:0.007053:0.006620:0.011299:0.009039:0.007053:0.014698:0.005182:0.011276:0.010957:0.007512:0.006209:0.009039:0.007807:0.017577:0.009085:0.011756:0.007053:0.009085:0.011596:0.011391:0.007053:0.014267:0.011071:0.011048:0.011502:0.009039:0.011756:0.007053:0.005433:0.009108:0.011254:0.010843:0.007898:0.008811:0.006209:0.010843:0.007807:0.005547:0.009039:0.007670:0.007053:0.006026:0.010843:0.007807:0.007053:0.011299:0.008948:0.004908:0.011071:0.006369:0.011550:0.005250:0.007053:0.011391:0.005615:0.007875:0.009108:0.011413:0.007693:0.007533
sions; Anne Snelting of the Utrecht Platform for Organoid Technology (U-PORT; UMC :@0.117647:0.188923:0.857121:0.188923:0.857121:0.168550:0.117647:0.168550:0.007601:0.005547:0.010843:0.011619:0.007670:0.004497:0.004018:0.014929:0.011756:0.011596:0.009039:0.004018:0.010112:0.011596:0.008948:0.004908:0.006437:0.005615:0.011459:0.009861:0.004018:0.010843:0.006209:0.004018:0.006620:0.011299:0.009039:0.004018:0.015043:0.006437:0.007442:0.009108:0.008765:0.011094:0.006437:0.004018:0.011824:0.005433:0.008811:0.006437:0.006026:0.010843:0.007807:0.017645:0.004018:0.006026:0.010843:0.007807:0.004018:0.016298:0.007624:0.009861:0.009085:0.011598:0.010843:0.005547:0.011391:0.004018:0.010866:0.009108:0.008765:0.011459:0.011596:0.010934:0.005182:0.011048:0.010546:0.009724:0.004018:0.006939:0.016024:0.007533:0.012167:0.016047:0.012804:0.012441:0.004497:0.004018:0.015499:0.019197:0.014678:0.004109
Utrecht) for patient inclusion and tissue acquisition; Maaike Vreeswijk and Lise van Wijk :@0.117647:0.209502:0.857153:0.209502:0.857153:0.189129:0.117647:0.189129:0.015043:0.006437:0.007442:0.009108:0.008765:0.011094:0.006437:0.006939:0.003515:0.006026:0.010843:0.007807:0.003515:0.011365:0.008811:0.006437:0.005547:0.009039:0.011391:0.006437:0.003515:0.005615:0.011596:0.008765:0.004908:0.011413:0.007601:0.005547:0.010843:0.011756:0.003515:0.009085:0.011596:0.011391:0.003515:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.003515:0.009291:0.008994:0.010706:0.011413:0.005615:0.007601:0.005273:0.006437:0.005547:0.010843:0.011756:0.004497:0.003515:0.019083:0.009382:0.009085:0.005750:0.010274:0.009039:0.003504:0.012899:0.007442:0.009106:0.009039:0.007761:0.014723:0.005273:0.005273:0.010523:0.003515:0.009085:0.011596:0.011391:0.003515:0.011733:0.005615:0.007875:0.009039:0.003515:0.009838:0.009085:0.011756:0.003515:0.019951:0.005273:0.005273:0.010523:0.004109
(Leiden University Medical Center) for providing ovarian cancer tissues for PDO cul-:@0.117647:0.230080:0.852941:0.230080:0.852941:0.209707:0.117647:0.209707:0.006939:0.011824:0.009039:0.005547:0.011322:0.009039:0.011756:0.005693:0.014883:0.011756:0.005547:0.009633:0.009039:0.007624:0.007601:0.005273:0.006437:0.009724:0.005695:0.018969:0.009106:0.011391:0.005547:0.009108:0.009405:0.005250:0.005695:0.014995:0.009039:0.011391:0.006211:0.009039:0.007807:0.006939:0.005693:0.006026:0.010843:0.007807:0.005693:0.011071:0.007442:0.010866:0.009838:0.005547:0.011391:0.005615:0.011459:0.009861:0.005695:0.010866:0.009838:0.009085:0.007807:0.005798:0.009085:0.011756:0.005693:0.009108:0.009085:0.011598:0.008994:0.009039:0.007807:0.005695:0.006437:0.005615:0.007533:0.007510:0.011345:0.009039:0.007670:0.005695:0.006024:0.010843:0.007807:0.005695:0.011664:0.016504:0.016412:0.005693:0.009108:0.011550:0.005250:0.007533
turing; Vera Deneer for input on clinical pharmacokinetics; Utrecht Sequencing Facility :@0.117647:0.250659:0.857089:0.250659:0.857089:0.230286:0.117647:0.230286:0.006163:0.011413:0.007807:0.005615:0.011459:0.009861:0.004497:0.004269:0.012737:0.009039:0.007898:0.009291:0.004269:0.016230:0.009039:0.011596:0.009108:0.009039:0.007807:0.004269:0.006026:0.010843:0.007807:0.004269:0.005615:0.011391:0.011046:0.011071:0.006437:0.004269:0.010840:0.011756:0.004269:0.008765:0.005250:0.005615:0.011756:0.005545:0.009108:0.009405:0.005250:0.004269:0.011162:0.011391:0.009085:0.007807:0.017577:0.009291:0.008994:0.010934:0.010706:0.005615:0.011596:0.009131:0.006437:0.005547:0.008994:0.007670:0.004497:0.004269:0.015043:0.006437:0.007442:0.009108:0.008765:0.011094:0.006437:0.004269:0.010592:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.004269:0.010729:0.009291:0.008994:0.005752:0.005250:0.005271:0.006437:0.009724:0.004109
and Hartwig Medical Foundation for providing sequencing service and data; Hans Bos :@0.117647:0.271238:0.857096:0.271238:0.857096:0.250865:0.117647:0.250865:0.009085:0.011596:0.011391:0.004908:0.016184:0.009087:0.007964:0.006437:0.014723:0.005615:0.009861:0.004908:0.018969:0.009108:0.011391:0.005547:0.009108:0.009405:0.005250:0.004908:0.010683:0.010820:0.011413:0.011596:0.011573:0.008811:0.006437:0.005547:0.010843:0.011756:0.004908:0.006026:0.010843:0.007807:0.004908:0.011071:0.007442:0.010866:0.009838:0.005547:0.011391:0.005615:0.011459:0.009861:0.004908:0.007875:0.009108:0.010706:0.011345:0.009039:0.011596:0.008994:0.005615:0.011459:0.009861:0.004908:0.007875:0.009039:0.008400:0.009838:0.005547:0.008994:0.009039:0.004908:0.009085:0.011596:0.011391:0.004908:0.011573:0.008811:0.006551:0.009291:0.004497:0.004908:0.016184:0.009085:0.011619:0.007670:0.004908:0.013080:0.010955:0.007670:0.004109
for acquiring funding; and the Dutch Cancer Registration (IKNL) for providing survival :@0.117647:0.291816:0.857027:0.291816:0.857027:0.271444:0.117647:0.271444:0.006026:0.010843:0.007807:0.003766:0.009291:0.008994:0.010706:0.011413:0.005615:0.007807:0.005615:0.011459:0.009861:0.003766:0.006366:0.011413:0.011598:0.011391:0.005615:0.011457:0.009861:0.004497:0.003766:0.009085:0.011596:0.011391:0.003766:0.006620:0.011299:0.009039:0.003766:0.016230:0.011071:0.006209:0.008765:0.011459:0.003766:0.014974:0.009085:0.011596:0.008994:0.009039:0.007807:0.003766:0.013696:0.009039:0.009861:0.005615:0.007510:0.006437:0.007898:0.008811:0.006437:0.005547:0.010843:0.011756:0.003766:0.006939:0.007259:0.014541:0.016230:0.011619:0.006939:0.003766:0.006026:0.010843:0.007807:0.003766:0.011071:0.007442:0.010866:0.009838:0.005547:0.011391:0.005615:0.011459:0.009861:0.003766:0.007510:0.011413:0.008400:0.009838:0.005547:0.009838:0.009405:0.005250:0.004109
data. The graphical abstract was created with BioRender.com. This work was supported :@0.117647:0.312395:0.857050:0.312395:0.857050:0.292022:0.117647:0.292022:0.011573:0.008811:0.006551:0.009291:0.004497:0.004725:0.011470:0.011311:0.009039:0.004725:0.009861:0.007898:0.008811:0.011162:0.011459:0.005547:0.009108:0.009405:0.005250:0.004725:0.009108:0.010934:0.007510:0.006437:0.007898:0.009291:0.009108:0.006437:0.004725:0.014723:0.009291:0.007670:0.004725:0.008994:0.007442:0.009291:0.008811:0.006209:0.009108:0.011391:0.004725:0.014723:0.005273:0.006617:0.011459:0.004725:0.012486:0.005547:0.011048:0.013696:0.009039:0.011596:0.011322:0.009039:0.006255:0.004497:0.008994:0.010843:0.017645:0.004497:0.004725:0.011470:0.011470:0.005615:0.007670:0.004725:0.014516:0.010845:0.007601:0.010523:0.004725:0.014723:0.009291:0.007670:0.004725:0.007510:0.011071:0.011048:0.011505:0.010843:0.007967:0.006209:0.009108:0.011391:0.004109
by Gieskes Strijbis Foundation (1816199), and two grants from the Dutch Cancer Soci-:@0.117647:0.332974:0.852941:0.332974:0.852941:0.312601:0.117647:0.312601:0.010843:0.009724:0.004634:0.015477:0.005547:0.009039:0.007556:0.010272:0.009039:0.007670:0.004634:0.009793:0.006437:0.007807:0.005273:0.005273:0.010820:0.005615:0.007670:0.004634:0.010683:0.010820:0.011413:0.011596:0.011573:0.008811:0.006437:0.005547:0.010843:0.011756:0.004634:0.006939:0.010432:0.010432:0.010432:0.010432:0.010432:0.010432:0.010432:0.006939:0.004497:0.004634:0.009085:0.011596:0.011391:0.004634:0.006437:0.014518:0.011048:0.004634:0.009861:0.007896:0.009087:0.011391:0.006437:0.007670:0.004634:0.006412:0.007442:0.010843:0.017645:0.004634:0.006620:0.011299:0.009039:0.004634:0.016230:0.011071:0.006209:0.008765:0.011459:0.004634:0.014974:0.009085:0.011596:0.008994:0.009039:0.007807:0.004634:0.010592:0.011276:0.008994:0.005615:0.007533
ety (UU2015-7743, RUG-2017-11352).:@0.117647:0.353553:0.450206:0.353553:0.450206:0.333180:0.117647:0.333180:0.009131:0.006437:0.009724:0.004109:0.006939:0.016024:0.016024:0.010432:0.010432:0.010432:0.010432:0.007533:0.010432:0.010432:0.010432:0.010432:0.004497:0.004109:0.012482:0.016024:0.015682:0.007533:0.010432:0.010432:0.010432:0.010432:0.007533:0.010432:0.010432:0.010432:0.010432:0.010432:0.006939:0.004497
 :@0.117647:0.374131:0.121756:0.374131:0.121756:0.353758:0.117647:0.353758:0.004109
Author contributions:@0.117647:0.418271:0.348090:0.418271:0.348090:0.390161:0.117647:0.390161:0.012144:0.013015:0.010343:0.013509:0.013132:0.013103:0.004648:0.012841:0.013132:0.013626:0.010343:0.013103:0.006217:0.012812:0.013015:0.010343:0.006217:0.013132:0.013626:0.012144
Conceptualization: CW, JEVI, RZ, PW, ES:@0.117647:0.460121:0.468835:0.460121:0.468835:0.439748:0.117647:0.439748:0.014997:0.010843:0.011596:0.008994:0.009131:0.011048:0.006163:0.011596:0.009405:0.005250:0.005615:0.008834:0.008811:0.006437:0.005545:0.010845:0.011756:0.004497:0.004109:0.014678:0.017392:0.004497:0.004109:0.006871:0.011893:0.015089:0.007259:0.004497:0.004109:0.013376:0.012966:0.004497:0.004109:0.012167:0.017394:0.004497:0.004109:0.012098:0.010112
Methodology: CW, JEVI, OK, HC, WK, ES:@0.117647:0.480700:0.478399:0.480700:0.478399:0.460327:0.117647:0.460327:0.018969:0.009131:0.006620:0.011299:0.011276:0.011322:0.010934:0.005182:0.011048:0.010546:0.010181:0.004497:0.004109:0.014678:0.017392:0.004497:0.004109:0.006871:0.011893:0.015089:0.007259:0.004497:0.004109:0.016047:0.014541:0.004497:0.004109:0.016412:0.014678:0.004497:0.004109:0.021001:0.014541:0.004497:0.004109:0.012098:0.010112
Software: JEVI, LN:@0.117647:0.501278:0.277937:0.501278:0.277937:0.480905:0.117647:0.480905:0.010592:0.010843:0.006197:0.006197:0.014723:0.009085:0.007442:0.009039:0.004497:0.004109:0.006871:0.011893:0.015089:0.007259:0.004497:0.004109:0.011619:0.016230
Validation: CW, NH, ES:@0.117647:0.521857:0.318865:0.521857:0.318865:0.501484:0.117647:0.501484:0.012874:0.009405:0.005250:0.005547:0.011573:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109:0.014678:0.017394:0.004497:0.004109:0.016230:0.016846:0.004497:0.004109:0.012098:0.010112
Formal analysis: CW, JEVI, NH, CV, TJ, PD, ES:@0.117647:0.542436:0.509900:0.542436:0.509900:0.522063:0.117647:0.522063:0.010683:0.010843:0.007807:0.017577:0.009405:0.005250:0.004109:0.009085:0.011687:0.009405:0.005182:0.009724:0.007601:0.005615:0.007670:0.004497:0.004109:0.014678:0.017394:0.004497:0.004109:0.006871:0.011893:0.015089:0.007259:0.004497:0.004109:0.016230:0.016846:0.004497:0.004109:0.014678:0.011480:0.004497:0.004109:0.013354:0.005615:0.004497:0.004109:0.011664:0.015111:0.004497:0.004109:0.012098:0.010112
Investigation: CW, NH, KL, OK, ES:@0.117647:0.563014:0.414530:0.563014:0.414530:0.542641:0.117647:0.542641:0.006894:0.011368:0.009633:0.009039:0.007510:0.006437:0.005615:0.009861:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109:0.014678:0.017394:0.004497:0.004109:0.016230:0.016846:0.004497:0.004109:0.014541:0.011619:0.004497:0.004109:0.016045:0.014541:0.004497:0.004109:0.012098:0.010112
Resources: CW, JEVI, KL, OK, TJ, LN, RZ, PW, ES:@0.117647:0.583593:0.535943:0.583593:0.535943:0.563220:0.117647:0.563220:0.013696:0.009039:0.007875:0.010820:0.011413:0.007442:0.008994:0.009039:0.007670:0.004497:0.004109:0.014678:0.017392:0.004497:0.004109:0.006871:0.011893:0.015089:0.007259:0.004497:0.004109:0.014541:0.011619:0.004497:0.004109:0.016047:0.014541:0.004497:0.004109:0.013354:0.005613:0.004497:0.004109:0.011619:0.016230:0.004497:0.004109:0.013376:0.012966:0.004497:0.004109:0.012167:0.017394:0.004497:0.004109:0.012098:0.010112
Data curation: CW, JEVI, ES:@0.117647:0.604172:0.355637:0.604172:0.355637:0.583799:0.117647:0.583799:0.016207:0.008811:0.006551:0.009291:0.004109:0.009106:0.011413:0.007898:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109:0.014678:0.017394:0.004497:0.004109:0.006871:0.011893:0.015089:0.007259:0.004497:0.004109:0.012098:0.010112
Writing - original draft preparation: CW, ES:@0.117647:0.624750:0.484608:0.624750:0.484608:0.604378:0.117647:0.604378:0.018809:0.007807:0.005273:0.006437:0.005615:0.011459:0.009861:0.004109:0.007533:0.004109:0.010843:0.007807:0.005615:0.009861:0.005615:0.011685:0.009405:0.005250:0.004109:0.011391:0.007898:0.009085:0.006197:0.006197:0.004109:0.011071:0.007442:0.009131:0.011368:0.009085:0.007898:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109:0.014678:0.017394:0.004497:0.004109:0.012098:0.010112
Writing - review and editing: All authors:@0.117647:0.645329:0.456666:0.645329:0.456666:0.624956:0.117647:0.624956:0.018809:0.007807:0.005273:0.006437:0.005615:0.011459:0.009861:0.004109:0.007533:0.004109:0.007442:0.009334:0.009838:0.005547:0.009336:0.014723:0.004109:0.009085:0.011596:0.011391:0.004109:0.009108:0.011391:0.005273:0.006437:0.005615:0.011459:0.009861:0.004497:0.004109:0.015063:0.005387:0.005250:0.004109:0.008811:0.011071:0.006620:0.011299:0.010843:0.007624:0.007670
Visualization: CW, JEVI, ES:@0.117647:0.665908:0.350113:0.665908:0.350113:0.645535:0.117647:0.645535:0.014038:0.005615:0.007510:0.011596:0.009405:0.005250:0.005615:0.008834:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109:0.014678:0.017392:0.004497:0.004109:0.006871:0.011893:0.015089:0.007259:0.004497:0.004109:0.012098:0.010112
Supervision: WK, EC, HS, RZ, PW, ES:@0.117647:0.686487:0.437674:0.686487:0.437674:0.666114:0.117647:0.666114:0.009793:0.011071:0.011505:0.009039:0.008400:0.009838:0.005615:0.007601:0.005547:0.010843:0.011756:0.004497:0.004109:0.021001:0.014541:0.004497:0.004109:0.012098:0.014678:0.004497:0.004109:0.016846:0.010112:0.004497:0.004109:0.013376:0.012966:0.004497:0.004109:0.012167:0.017389:0.004497:0.004109:0.012098:0.010112
Project administration: CW, ES:@0.117647:0.707065:0.379970:0.707065:0.379970:0.686692:0.117647:0.686692:0.011916:0.007442:0.010820:0.005341:0.009108:0.009108:0.006437:0.004109:0.009291:0.011391:0.017645:0.005615:0.011756:0.005615:0.007508:0.006437:0.007898:0.008811:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109:0.014678:0.017394:0.004497:0.004109:0.012098:0.010112
Funding acquisition: HC, WK, RZ, PW:@0.117647:0.727644:0.447857:0.727644:0.447857:0.707271:0.117647:0.707271:0.010729:0.011413:0.011596:0.011391:0.005615:0.011459:0.009861:0.004109:0.009291:0.008994:0.010706:0.011413:0.005615:0.007601:0.005273:0.006437:0.005547:0.010843:0.011756:0.004497:0.004109:0.016410:0.014678:0.004497:0.004109:0.021001:0.014541:0.004497:0.004109:0.013376:0.012966:0.004497:0.004109:0.012167:0.021001
 :@0.117647:0.748223:0.121756:0.748223:0.121756:0.727850:0.117647:0.727850:0.004109